Search Results - "Micetich, Kenneth"

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma by Ben-Josef, Edgar, Guthrie, Katherine A, El-Khoueiry, Anthony B, Corless, Christopher L, Zalupski, Mark M, Lowy, Andrew M, Thomas, Jr, Charles R, Alberts, Steven R, Dawson, Laura A, Micetich, Kenneth C, Thomas, Melanie B, Siegel, Abby B, Blanke, Charles D

“…The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year…”
Get full text

The depth of post-treatment perirectal tissue invasion is a predictor of outcome in patients with clinical T3N1M0 rectal cancer treated with neoadjuvant chemoradiation followed by surgical resection by Brandt, Whitney S., B.S, Yong, Sherri, M.D, Abood, Gerard, M.D., M.S, Micetich, Kenneth, M.D, Walther, Ashley, M.D, Shoup, Margo, M.D., F.A.C.S

“…Abstract Background To determine if patients with clinical stage III rectal cancer treated with neoadjuvant chemoradiotherapy (CRT) and surgery have an…”
Get full text

Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors by Paner, Gladell P, Silberman, Simone, Hartman, Grace, Micetich, Kenneth C, Aranha, Gerard V, Alkan, Serhan

“…Several signaling pathways have been recognized in normal c-kit-mediated signal transduction following stem cell factor (SCF) stimulation including Janus…”
Get more information

Four hundred fifty-three consecutive pancreaticoduodenectomies with pancreaticogastrostomy by Eguia, Emanuel, O'Halloran, Eileen A., Borge, Marc A., Micetich, Kenneth, Aranha, Gerard V.

“…Patients who undergo pancreaticoduodenectomy (PD) have the pancreatic remnant (PR) anastomosed to the jejunum. In this study, all patients had the PR…”
Get full text

SWOG 0941: A phase II study of sorafenib and erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma by El-Khoueiry, Anthony B., Rankin, Cathryn J, Iqbal, Syma, Micetich, Kenneth C., Kayaleh, Omar, Lenz, Heinz-Josef, Blanke, C. D.

“…Abstract only 4113 Background: The treatment of pts with advanced biliary cancers represents a therapeutic challenge. The vascular endothelial growth factor…”
Get full text

SWOG S0809: A phase II trial of adjuvant capecitabine (cap)/gemcitabine (gem) followed by concurrent capecitabine and radiotherapy in extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBCA) by Ben-Josef, Edgar, Guthrie, Katherine, El-Khoueiry, Anthony B., Corless, Christopher L., Zalupski, Mark, Lowy, Andrew M., Thomas, Charles R., Alberts, Steven R., Dawson, Laura A., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B., Blanke, Charles David

“…Abstract only…”
Get full text

The Ethics of Competition in Liver Transplantation by THOMASMA, DAVID C., MICETICH, KENNETH C., BREMS, JOHN, VAN THIEL, DAVID

“…The behavior of people in the presence of scarce resources has long been a source of ethical concern and debate. Many of the responses, ranging from outright…”
Get full text

Competing Clinical Trials in the Same Institution: Ethical Issues in Subject Selection and Informed Consent by Gordon, Elisa J., Micetich, Kenneth C.

Get full text

Sweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature by Sobol, Urszula A., Sherman, Karen L., Smith, Jason, Nagda, Suneel N., Micetich, Kenneth, Nickoloff, Brian J., Shoup, Margo C.

“…Background  Sweet's syndrome, also known as febrile neutrophilic dermatosis, can occur in patients with an underlying malignancy and can present with…”
Get full text

Are intravenous fluids morally required for a dying patient? by Micetich, K C, Steinecker, P H, Thomasma, D C

Get more information

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma by Sparano, J A, Fisher, R I, Sunderland, M, Margolin, K, Ernest, M L, Sznol, M, Atkins, M B, Dutcher, J P, Micetich, K C, Weiss, G R

“…To compare the response rate, survival, and toxicity of treatment with high-dose intravenous (IV) bolus interleukin-2 (IL-2) plus interferon alfa-2a…”
Get more information

Reflection of an IRB Chair by Micetich, Kenneth Craig

“…I have been a member of the Loyola University of Chicago, Medical Center Institutional Review Board (IRB) for 12 years and Chair for the last 4 years. The…”
Get full text

The Ethical Problems of the Open Label Extension Study by Micetich, Kenneth Craig

“…The institutional review board (IRB) Is charged with assessing the risks and benefits of research projects Involving human subjects. Ethical considerations and…”
Get full text

Reflections of an IRB chair by Micetich, K C

Get full text

Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells by MICETICH, K, ZWELLING, L. A, KOHN, K. W

“…A line of mouse leukemia L1210 cells resistant to cis-diamminedichloroplatinum(II) (cis-DDP) was compared with its parent cell line in order to determine…”
Get full text

Author's reply: Medical ethics by Micetich, Kenneth C., Thomasma, David C.

Get full text

Exaggerated response to insect bites. An unusual cutaneous manifestation of chronic lymphocytic leukemia by Kolbusz, R V, Micetich, K, Armin, A R, Massa, M C

Get more information

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells by MICETICH, K. C, BARNES, D, ERICKSON, L. C

“…Utilizing the DNA alkaline elution technique we have compared qualitatively and quantitatively the DNA lesions produced in L1210 cells after a 2 h exposure to…”
Get full text

The ethics of patient requests in experimental medicine by Micetich, Kenneth C., Thomasma, David C.

Get full text

Continuance of nutritional care in the terminally ill patient by Thomasma, D C, Micetich, K C, Steinecker, P H

“…Food and water can be naturally delivered to dying patients, or they can be medically delivered. If medically delivered, they are called nutrition and fluids…”
Get more information